Suppr超能文献

相似文献

1
Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.
Biochem J. 2002 Nov 1;367(Pt 3):907-11. doi: 10.1042/BJ20021085.
2
Potentiation of glucocorticoid receptor transcriptional activity by sumoylation.
Endocrinology. 2002 Sep;143(9):3482-9. doi: 10.1210/en.2002-220135.
3
Sumoylation increases HIF-1alpha stability and its transcriptional activity.
Biochem Biophys Res Commun. 2004 Nov 5;324(1):394-400. doi: 10.1016/j.bbrc.2004.09.068.
6
SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx.
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):16973-8. doi: 10.1073/pnas.0504460102. Epub 2005 Nov 15.
7
Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Mol Cell Biol. 2005 Aug;25(16):6964-79. doi: 10.1128/MCB.25.16.6964-6979.2005.
8
Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization.
Biochem Soc Trans. 2007 Dec;35(Pt 6):1397-400. doi: 10.1042/BST0351397.
9
Effects of SUMO-1 upon Epstein-Barr virus BZLF1 function and BMRF1 expression.
Biochem Biophys Res Commun. 2005 Oct 14;336(1):22-8. doi: 10.1016/j.bbrc.2005.08.036.

引用本文的文献

2
Phosphorylation-induced SUMOylation promotes Ulk4 condensation at the ciliary tip to transduce Hedgehog signal.
J Cell Sci. 2025 Oct 15;138(20). doi: 10.1242/jcs.263695. Epub 2025 May 19.
3
4
Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia.
Hemasphere. 2023 Jun 22;7(7):e916. doi: 10.1097/HS9.0000000000000916. eCollection 2023 Jul.
5
Signalling mechanisms and cellular functions of SUMO.
Nat Rev Mol Cell Biol. 2022 Nov;23(11):715-731. doi: 10.1038/s41580-022-00500-y. Epub 2022 Jun 24.
6
Impact of RSUME Actions on Biomolecular Modifications in Physio-Pathological Processes.
Front Endocrinol (Lausanne). 2022 Apr 21;13:864780. doi: 10.3389/fendo.2022.864780. eCollection 2022.
7
SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma.
J Exp Clin Cancer Res. 2022 Jan 4;41(1):8. doi: 10.1186/s13046-021-02226-9.
9
Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer.
Int J Mol Sci. 2021 Apr 24;22(9):4446. doi: 10.3390/ijms22094446.
10

本文引用的文献

1
PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.
Mol Cell Biol. 2002 Jul;22(14):5222-34. doi: 10.1128/MCB.22.14.5222-5234.2002.
2
Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2872-7. doi: 10.1073/pnas.052559499. Epub 2002 Feb 26.
3
SUMO-1 targets RanGAP1 to kinetochores and mitotic spindles.
J Cell Biol. 2002 Feb 18;156(4):595-602. doi: 10.1083/jcb.200110109.
4
Ubc9 is a novel modulator of the induction properties of glucocorticoid receptors.
J Biol Chem. 2002 Apr 12;277(15):12541-9. doi: 10.1074/jbc.M112330200. Epub 2002 Jan 25.
5
The nucleoporin RanBP2 has SUMO1 E3 ligase activity.
Cell. 2002 Jan 11;108(1):109-20. doi: 10.1016/s0092-8674(01)00633-x.
8
Involvement of PIAS1 in the sumoylation of tumor suppressor p53.
Mol Cell. 2001 Sep;8(3):713-8. doi: 10.1016/s1097-2765(01)00349-5.
9
An E3-like factor that promotes SUMO conjugation to the yeast septins.
Cell. 2001 Sep 21;106(6):735-44. doi: 10.1016/s0092-8674(01)00491-3.
10
Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification.
Mol Cell Biol. 2001 May;21(10):3314-24. doi: 10.1128/MCB.21.10.3314-3324.2001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验